After 7 weeks of treatment, longitudinal arthritis clinical scores indicated that only dual blockade of CSF1 and IL34 or TNFRII-Fc treatments were protective in CIA (Figure 2A). This evidence concerns the gene IL34 and arthritic joint disease.